Tag: self-administered parenteral market outlook

  • 2024-2033 Self-Administered Parenteral Market Forecast: Predicted Growth Rate and Market Size

    2024-2033 Self-Administered Parenteral Market Forecast: Predicted Growth Rate and Market Size

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Self-Administered Parenteral Market from 2024 to 2033?

    The self-administered parenteral market has seen robust growth, anticipated to grow from $23.14 billion in 2023 to $24.57 billion in 2024, at a CAGR of 6.1%. Key drivers include the increase in chronic diseases, an aging population, government initiatives, patient education, and rising incidences of bone disorders.

    The self-administered parenteral market is expected to see steady growth, projected to reach $29.8 billion by 2028 at a CAGR of 4.9%. This growth is attributed to the rising preference for home healthcare, telemedicine, remote patient monitoring, and patient support initiatives, alongside growing personalized medicine. Major trends include the integration of digital health solutions, customized drug delivery systems, the emergence of targeted therapies, and advancements in biologics.

    Claim Your Free Sample of the Global Self-Administered Parenteral Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

    What Key Factors Are Fueling the Growth of the Self-Administered Parenteral Market?

    The rising incidence of chronic diseases is anticipated to boost the self-administered parenteral market. These products allow individuals to manage chronic conditions independently, improving adherence to treatment. The National Institutes of Health projected a 99.5% increase in chronic disease cases among those aged 50 and above by 2050.

    What Are the Major Segments of the Self-Administered Parenteral Market?

    1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products

    2) By Usage: Disposable, Reusable

    3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels

    4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

    What New Trends Are Transforming the Self-Administered Parenteral Market?

    Companies in the self-administered parenteral market are innovating products like the UDENYCA autoinjector to increase patient accessibility. In May 2023, Coherus BioSciences launched this device for reliable delivery of pegfilgrastim.

    Order Now for Fast Delivery of Your Self-Administered Parenteral Market Report!

    https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

    Which Regions Are Driving Growth in the Self-Administered Parenteral Market?

    North America was the largest region in the self-administered parenteral market in 2023. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Self-Administered Parenteral Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the self-administered parenteral market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Self-Administered Parenteral Market Include

    1. Self-Administered Parenteral Market Executive Summary

    2. Self-Administered Parenteral Market Segments

    3. Self-Administered Parenteral Market Size And Template Market Growth Rate

    4. Key Self-Administered Parenteral Market Trends

    5. Major Self-Administered Parenteral Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Self-Administered Parenteral Market

    26. Top Self-Administered Parenteral Companies

    27. Self-Administered Parenteral Market Opportunities And Strategies

    28. Self-Administered Parenteral Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Payer Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/payer-services-global-market-report

    Personal Computers Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/personal-computers-global-market-report

    Mineral And Bone Disorder Treatment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Growth Forecast For The Self-Administered Parenteral Global Market 2024-2033

    Future Growth Forecast For The Self-Administered Parenteral Global Market 2024-2033

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The self-administered parenteral market is experiencing robust growth, expanding from $23.14 billion in 2023 to $24.57 billion in 2024, at a compound annual growth rate (CAGR) of 6.1%.

    • Market Growth: $23.14 billion in 2023 to $24.57 billion in 2024
    • CAGR: 6.1%

    Historical Growth Drivers

    Several factors have contributed to the market’s growth in recent years.

    • Chronic Diseases: Increasing prevalence of chronic conditions
    • Aging Population: Rising number of elderly individuals
    • Government Initiatives: Policies to promote patient self-management
    • Patient Education: Programs to educate and support patients
    • Bone Disorders: Higher incidences of related health issues

    Future Market Projections

    The self-administered parenteral market is poised for steady growth, projected to reach $29.8 billion by 2028, at a CAGR of 4.9%.

    • Market Projection: $29.8 billion by 2028
    • CAGR: 4.9%

    View More On The Self-Administered Parenteral Market Report 2024 – https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

    Forecasted Growth Drivers

    Key factors expected to drive future market growth include:

    • Home Healthcare: Increasing preference for home-based care
    • Telemedicine: Growth of remote patient monitoring
    • Patient Initiatives: Continued education and support
    • Personalized Medicine: Expansion of tailored treatments

    Major Trends in the Market

    Several significant trends are expected to shape the market landscape.

    • Digital Health Solutions: Integration of advanced technologies
    • Customized Drug Delivery: Development of tailored delivery systems
    • Targeted Therapies: Emergence of precise treatment options
    • Biologics Advancements: Innovations in biological medications

    Chronic Diseases Fuel Market Expansion

    The prevalence of chronic diseases significantly contributes to market growth.

    • Disease Management: Self-administered parenterals improve adherence
    • Population Statistics: Expected increase in chronic disease cases among those aged 50 and above
      • 5% increase in chronic disease cases from 2020 to 2050

    Key Market Players

    Several major companies are prominent in the self-administered parenteral market.

    • Leading Companies: Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., and AstraZeneca PLC

    Innovative Autoinjector Solutions

    Companies are focusing on innovative products to enhance patient treatment.

    • Example Product: UDENYCA autoinjector by Coherus BioSciences Inc.
      • Features: Intuitive design, fast dosing, at-home and in-office use

    Halozyme Therapeutics’ Strategic Acquisition

    Halozyme Therapeutics Inc. acquired Antares Pharma Inc. to strengthen its market position.

    • Acquisition Value: $960 million
    • Objective: Expand platform technologies and capabilities

    Market Segmentation

    The self-administered parenteral market is segmented into several categories.

    • By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
    • By Usage: Disposable, Reusable
    • By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Channels
    • By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

    Regional Insights

    North America was the largest region in the self-administered parenteral market in 2023.

    • Leading Region: North America

    Conclusion

    The self-administered parenteral market is on a growth trajectory, driven by increasing chronic diseases, technological advancements, and strategic acquisitions. With ongoing innovations and rising patient preference for home healthcare, the market is set to continue its expansion in the coming years.

    Request A Sample Of The Global Self-Administered Parenteral Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13927&type=smp